Redmile Group LLC 13D and 13G filings for LAVA Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,074,372 7.900% |
-741,824 (-26.34%) |
Filing |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,816,196 10.900% |
-8,213 (-0.29%) |
Filing |
| 2021-04-08 4:11 pm Purchase |
2021-03-29 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,824,409 11.100% |
2,824,409 (New Position) |
Filing |